A major problem is and will continue to be cost. Ivacaftor, that cystic fibrosis treatment we mentioned before, will only be used by a few thousand people in the United States. There is probably no economy of scale to be had. So that treatment costs about $300,000 a year. Unless we arrive at extremely generalized cheap methods for drug preparation, it will be hard to drive down the cost of a product with so few consumers.
